Advertisement
U.S. markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
7.340.00 (0.00%)
At close: 04:00PM EDT
7.37 +0.03 (+0.41%)
After hours: 06:08PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts18181815
Avg. Estimate-0.49-0.49-1.93-1.81
Low Estimate-0.67-0.65-2.62-2.12
High Estimate-0.43-0.38-1.28-1.43
Year Ago EPS-0.19-0.54-1.64-1.93
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts14141613
Avg. Estimate1.11M1.13M4.2M2.91M
Low EstimateN/AN/AN/AN/A
High Estimate5M5M20M20M
Year Ago Sales58.98M5.53M65.53M4.2M
Sales Growth (year/est)-98.10%-79.60%-93.60%-30.70%
Earnings History3/30/20236/29/20239/29/202312/30/2023
EPS Est.-0.62-0.59-0.57-0.52
EPS Actual-0.19-0.54-0.46-0.45
Difference0.430.050.110.07
Surprise %69.40%8.50%19.30%13.50%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.49-0.49-1.93-1.81
7 Days Ago-0.49-0.49-1.97-1.83
30 Days Ago-0.52-0.51-2.03-1.66
60 Days Ago-0.52-0.51-2.03-1.66
90 Days Ago-0.53-0.53-2.03-1.72
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2231
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesFATEIndustrySector(s)S&P 500
Current Qtr.-157.90%N/AN/AN/A
Next Qtr.9.30%N/AN/AN/A
Current Year-17.70%N/AN/AN/A
Next Year6.20%N/AN/AN/A
Next 5 Years (per annum)-37.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A